During development, Dvl1 was expressed at a high level in skeletal muscle at E18 and at birth, but the expression Biochemically, the MuSK-Dvl1 interaction was dose dependent and saturable, with an EC50 value of 3.86 Ϯ level decreased as development progressed (Figure 2A ). This pattern was similar to that of MuSK (Figure 2A ) 0.26 nM in ELISA-based binding assays ( Figure 1F ). Of the Dvl1 mutants, only DEP was able to bind to MuSKic (Valenzuela et al., 1995) . In addition, Dvl1 was readily detectable in myoblasts as well as myotubes (Figure with similar affinity (1.44 Ϯ 0.23 nM); binding of DIX or PDZ was barely detectable. Note that the maximal 2B). Denervation of skeletal muscles caused rapid degeneration of presynaptic nerves. Expression of postbinding of Dvl is twice that of DEP, probably due to dimerization. Taken together, these results demonstrate synaptic proteins was normal or elevated to compensate the loss of presynaptic input (Tanowitz and Mei, 1996) . that MuSK, via the juxtamembrane and kinase domains, interacts directly with the DEP domain of Dvl1.
While actin remained unchanged, expression of Dvl1 1 and 2, motes the association of MuSK with PAK1 as part of a ternary complex. Figure 7B ). Dvl1 had no effect on Agrin-induced PAK 
